−3.8 PLN
−13.69 M PLN
0.00 PLN
4.45 M
About BIOCELTIX
Sector
Industry
CEO
Lukasz Piotr Bzdzion
Website
Headquarters
Wroclaw
Founded
2018
ISIN
PLBCLTX00019
FIGI
BBG013DQ9F61
Bioceltix SA engages in the research and development in the area of veterinary medicine. It develops stem cell therapy for animal use. The company was founded on August 13, 2018 and is headquartered in Wroclaw, Poland.
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Related stocks
Frequently Asked Questions
The current price of BCX is 99.4 PLN — it has decreased by −0.80% in the past 24 hours. Watch BIOCELTIX stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GPW exchange BIOCELTIX stocks are traded under the ticker BCX.
BCX stock has fallen by −0.20% compared to the previous week, the month change is a 7.11% rise, over the last year BIOCELTIX has showed a 20.05% increase.
We've gathered analysts' opinions on BIOCELTIX future price: according to them, BCX price has a max estimate of 110.00 PLN and a min estimate of 110.00 PLN. Watch BCX chart and read a more detailed BIOCELTIX stock forecast: see what analysts think of BIOCELTIX and suggest that you do with its stocks.
BCX stock is 2.02% volatile and has beta coefficient of −0.15. Track BIOCELTIX stock price on the chart and check out the list of the most volatile stocks — is BIOCELTIX there?
Today BIOCELTIX has the market capitalization of 489.49 M, it has increased by 0.71% over the last week.
Yes, you can track BIOCELTIX financials in yearly and quarterly reports right on TradingView.
BCX net income for the last quarter is −3.45 M PLN, while the quarter before that showed −4.23 M PLN of net income which accounts for 18.38% change. Track more BIOCELTIX financial stats to get the full picture.
No, BCX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Mar 31, 2025, the company has 28 employees. See our rating of the largest employees — is BIOCELTIX on this list?
Like other stocks, BCX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BIOCELTIX stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So BIOCELTIX technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating BIOCELTIX stock shows the buy signal. See more of BIOCELTIX technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.